M.A. Bredella is professor of radiology, vice chair, Department of Radiology, Massachusetts General Hospital, and director, KL2/Catalyst Medical Research Investigator Training Program, Harvard Catalyst, The Harvard Clinical and Translational Science Center, Harvard Medical School, Boston, Massachusetts.
D.M. Rubio is professor of medicine, biostatistics, bioinformatics, and clinical and translational science, assistant vice chancellor for clinical research education and training, Health Sciences, director, Institute for Clinical Research Education, and director, KL2, Team Science, and Workforce Development, Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.
Acad Med. 2022 Sep 1;97(9):1311-1316. doi: 10.1097/ACM.0000000000004645. Epub 2022 Mar 8.
In addition to restrictions on conducting research, COVID-19-related travel bans and scientific meeting cancellations have negatively affected scholars in the Clinical and Translational Science Award (CTSA) Mentored Career Development Award (KL2) program. In response, a national virtual visiting scholar program was developed to provide opportunity for KL2 scholars to be virtual visiting professors at another CTSA hub, meet faculty and scholars, and expand networks and build collaborations. This article describes the design and short-term outcomes of the virtual CTSA Visiting Scholar Program. In 2020, a working group designed core program elements and developed an application and selection process. Anonymized surveys were sent to scholars post visit and to scholars and program directors 6 months post visit to evaluate their experience and solicit suggestions for improvements. Between November 2020 and May 2021, 56 KL2 scholars and 27 hubs participated. Forty-five (80.4%) participating scholars responded to the initial survey. Nearly all scholars (44, 97.7%) agreed their experience was valuable. All respondents indicated they would recommend the program to other KL2 scholars. For the 6-month survey, the response rate was 87.5% (49/56). Within 6 months of their visit, 36 (73.5%) respondents had contacted at least one person at the host hub and for 17 (34.7%) respondents, new collaborations with the host hub ensued. Twenty-five of 27 (92.6%) host hubs responded to the survey. Most (21, 84.0%) agreed that hearing visiting scholar talks was valuable to their own scholars and 23 (92%) indicated likelihood of their hub participating in future round of the program. The virtual Visiting Scholar Program provided KL2 scholars an opportunity to virtually visit another CTSA hub, present their research, and meet with faculty and other scholars to expand their networks. Although geared to KL2 scholars, this model is potentially generalizable to other nationally coordinated career development programs.
除了对研究的限制外,与 COVID-19 相关的旅行禁令和科学会议取消也对临床和转化科学奖 (CTSA) 指导职业发展奖 (KL2) 计划的学者产生了负面影响。为应对这种情况,制定了一项全国性的虚拟访问学者计划,为 KL2 学者提供在另一个 CTSA 中心担任虚拟访问教授的机会,与教职员工和学者会面,扩展网络并建立合作关系。本文介绍了虚拟 CTSA 访问学者计划的设计和短期成果。2020 年,一个工作组设计了核心计划要素,并制定了申请和选拔程序。在访问结束后向学者发送了匿名调查,在访问结束后 6 个月向学者和项目主任发送了调查,以评估他们的经验并征求改进建议。2020 年 11 月至 2021 年 5 月期间,有 56 名 KL2 学者和 27 个中心参与了该计划。45 名(80.4%)参与调查的学者回复了最初的调查。几乎所有学者(44 名,97.7%)都认为他们的经验很有价值。所有受访者都表示他们会向其他 KL2 学者推荐该计划。对于 6 个月的调查,回复率为 87.5%(49/56)。在访问后的 6 个月内,36 名(73.5%)受访者至少与主办中心的一名人员进行了联系,对于 17 名(34.7%)受访者,与主办中心产生了新的合作关系。27 个中心中的 25 个(92.6%)对调查做出了回应。大多数中心(21 个,84.0%)认为听取访问学者的演讲对他们自己的学者很有价值,23 个中心(92%)表示他们所在的中心有可能参加未来一轮的该计划。虚拟访问学者计划为 KL2 学者提供了一个机会,可以虚拟访问另一个 CTSA 中心,展示他们的研究,并与教职员工和其他学者会面,以扩展他们的网络。虽然该计划主要面向 KL2 学者,但这种模式可能适用于其他全国性协调的职业发展计划。